Cargando…
ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
BACKGROUND: Based on promising results over the past 10 years, the method of extracorporeal membrane oxygenation (ECMO) has developed from being used as a ‘rescue therapy’ to become an accepted treatment option for patients with acute lung failure (ARDS). Subsequently, the indication was extended al...
Autores principales: | Banjas, Norbert, Hopf, Hans-Bernd, Hanisch, Ernst, Friedrichson, Benjamin, Fichte, Julia, Buia, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299557/ https://www.ncbi.nlm.nih.gov/pubmed/30598825 http://dx.doi.org/10.1186/s40560-018-0352-2 |
Ejemplares similares
-
Correction to: ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
por: Banjas, Norbert, et al.
Publicado: (2019) -
Septic shock: ECMO beyond ARDS? Introducing the Simon two-stage protocol when randomisation is considered unethical
por: Buia, Alexander, et al.
Publicado: (2020) -
Should ECMO be used in cardiogenic shock?
por: Gokalp, Orhan, et al.
Publicado: (2019) -
ECMO in cardiac arrest and cardiogenic shock
por: Napp, L. C., et al.
Publicado: (2017) -
Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017)